BTG plc (LON:BTG – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 840 ($10.63) and traded as high as GBX 840 ($10.63). BTG shares last traded at GBX 840 ($10.63), with a volume of 271,742 shares trading hands.
BTG Stock Performance
The business’s 50-day moving average is GBX 840 and its 200-day moving average is GBX 840. The company has a market capitalization of £3.26 billion and a PE ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Further Reading
- Five stocks we like better than BTG
- What is the Euro STOXX 50 Index?
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- The How and Why of Investing in Gold Stocks
- Williams-Sonoma Stock: Buy It and Never Let It Go
- About the Markup Calculator
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
